Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

41.95
Delayed Data
As of 1:42pm ET
 -0.28 / -0.66%
Today’s Change
33.50
Today|||52-Week Range
115.39
-35.38%
Year-to-Date

Today’s Trading

Previous close42.23
Today’s open42.23
Day’s range41.05 - 42.25
Volume162,836
Average volume (3 months)748,896
Market cap$1.6B
Dividend yield--
Data as of 1:42pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-98.11%
Earnings growth (this year)-38.60%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.55%
P/E ratioNM
Price/Sales41.10
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...+0.16+1.24%
LXRXLexicon Pharmaceutic...+0.19+1.21%
TXMDTherapeuticsMD Inc-0.06-0.77%
SAGESAGE Therapeutics In...-0.71-1.60%
Data as of 1:57pm ET, 07/25/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.30
Annual revenue (last year)$59.1M
Annual profit (last year)-$117.7M
Net profit margin-199.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Senior Vice President-Finance &
Contact Person
Glenn Goddard
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs